Mechanisms of Drug Disposition During Pregnancy
怀孕期间的药物处置机制
基本信息
- 批准号:9069781
- 负责人:
- 金额:$ 100.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:ABCG2 geneAddressAdultAffectBlood CirculationCYP2B6 geneCYP2D6 geneCYP3A4 geneClinicalClinical DataCytochrome P450DataDiabetes MellitusDoseDrug DesignDrug EffluxDrug KineticsDrug abuseDrug toxicityDrug usageEnzymesExposure toFetusFundingGestational AgeGoalsGrowthHIVHIV InfectionsHIV Protease InhibitorsHealthHepaticHormonesHypertensionIllicit DrugsIndinavirInfectionKnowledgeLabelLightLiteratureLiverMaternal ExposureMental DepressionMetabolismMethadoneMineralsModelingMorbidity - disease rateMothersNeonatalOrphanPerinatal ExposurePharmaceutical PreparationsPharmacologyPhysiologicalPlacentaPlasmaPopulationPostpartum PeriodPregnancyPregnant WomenPublishingRegimenRegulationReportingResearch Project GrantsRiskRisk FactorsSafetySurveysSystemTeratogensTestingTherapeuticUnited States National Institutes of HealthVirus DiseasesVitaminsVulnerable PopulationsXenobioticsage relatedbasedrug efficacydrug mechanismdrug of abusefetalfetal drug exposurefetus drug adverse effectillicit drug useinterestmaternal morbiditymultidisciplinarynovelpharmacokinetic modelprogramsrisk benefit ratiosmoking cessationstatistics
项目摘要
DESCRIPTION (provided by applicant): Illicit drug use during pregnancy is a major risk factor for maternal and fetal morbidity. In addition, licit drugs are routinely administered to pregnant women, and therefore their fetuses, without the necessary data about the pharmacokinetics of these drugs in these vulnerable populations. The overall goal of this POI is to make use of drugs during pregnancy efficacious (licit drugs) and safer (licit and illicit drugs). We will achieve thi goal by testing the following overarching and unifying central hypothesis: Expression and activity of hepatic cytochrome P450 enzymes and placental drug transporters during pregnancy are regulated by pregnancy- related hormones and/or growth factors and by exposure to drugs and xenobiotics. Elucidating these mechanisms and quantifying the pregnancy-induced changes in these CYP and transporter activities will allow PBPK prediction of changes in maternal-fetal exposure to drugs througout pregnancy. The P450 enzymes and transporters we will study are those likely to be quantitatively most important for metabolism and transport of both illicit and licit drugs in the liver or the placenta, namely CYP3A (Project 1), CYP2B6 and CYP2D6 (Project 2), P-gp and BCRP (Project 3), and OCTS, NET, and SERT (Project 4). Pregnancy is known to induce expression and activity of hepatic CYP3A and CYP2D6, thus possibly lowering maternal exposure to drugs and potentially decreasing their efficacy. In the placenta, P-gp and BCRP participate in the efflux of drugs from the fetal compartment to the maternal circulation, thus protecting the fetus from adverse effects of drugs, while 0CT3, NET and/or SERT function to allow the entry of potentially toxic drugs into the fetal circulation. Thi POI uses a collaborative, synergistic, multidisciplinary and systems pharmacology approach to test the above-stated hypothesis. Results obtained from the proposed studies will allow us to predict how maternal and fetal exposure to licit and illicit drugs is affected by pregnancy and by gestational age and will reveal interesting and potentially novel mechanisms on physiological regulation of CYPs and transporters studied.
描述(申请人提供):怀孕期间使用非法药物是孕产妇和胎儿发病率的主要风险因素。此外,合法药物通常用于孕妇,因此也就是她们的胎儿,而没有关于这些药物在这些脆弱人群中的药代动力学的必要数据。该方案的总体目标是在怀孕期间使用有效的药物(合法药物)和更安全的药物(合法和非法药物)。我们将通过检验以下最重要和统一的中心假设来实现这一目标:妊娠期间肝脏细胞色素P450酶和胎盘药物转运蛋白的表达和活性受妊娠相关激素和/或生长因子以及药物和外源物质的影响。阐明这些机制并量化妊娠引起的这些细胞色素P450和转运蛋白活性的变化,将使PBPK能够预测怀孕期间母婴暴露于药物的变化。我们将研究的P450酶和转运体是那些可能在数量上对非法和合法药物在肝脏或胎盘中的新陈代谢和运输最重要的酶和转运体,即CYP3A(项目1)、CYP2B6和CYP2D6(项目2)、P-gp和BCRP(项目3),以及OCTS、NET和SERT(项目4)。已知怀孕会诱导肝脏细胞色素P3A和细胞色素P450 2 D6的表达和活性,因此可能会降低母亲对药物的暴露,并可能降低其疗效。在胎盘中,P-gp和BCRP参与药物从胎儿隔室到母体循环的外流,从而保护胎儿免受药物的不良影响,而0CT3、NET和/或SERT的功能允许潜在的有毒药物进入胎儿循环。THI POI使用协作、协同、多学科和系统药理学的方法来检验上述假设。拟议的研究结果将使我们能够预测孕妇和胎儿对合法和非法药物的暴露如何受到怀孕和胎龄的影响,并将揭示有趣的和潜在的新机制,对所研究的细胞色素P450和转运蛋白进行生理调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASHVANT D Unadkat其他文献
JASHVANT D Unadkat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASHVANT D Unadkat', 18)}}的其他基金
Identification, Quantification, and Functional Characterization of Transporters in Human Placenta, Developing Gut and Fetal Brain
人胎盘、肠道和胎儿大脑发育中转运蛋白的鉴定、定量和功能表征
- 批准号:
10746192 - 财政年份:2023
- 资助金额:
$ 100.29万 - 项目类别:
PBPK prediction and verification of maternal-fetal exposure to cannabinoids
母胎大麻素暴露的 PBPK 预测和验证
- 批准号:
10688214 - 财政年份:2013
- 资助金额:
$ 100.29万 - 项目类别:
Pharmacology of Drugs of Abuse During Pregnancy
怀孕期间滥用药物的药理学
- 批准号:
10688212 - 财政年份:2013
- 资助金额:
$ 100.29万 - 项目类别:
PBPK prediction and verification of maternal-fetal exposure to cannabinoids
母胎大麻素暴露的 PBPK 预测和验证
- 批准号:
10231037 - 财政年份:2013
- 资助金额:
$ 100.29万 - 项目类别:
Pharmacology of Drugs of Abuse During Pregnancy
怀孕期间滥用药物的药理学
- 批准号:
10463599 - 财政年份:2013
- 资助金额:
$ 100.29万 - 项目类别:
Pharmacology of Drugs of Abuse During Pregnancy
怀孕期间滥用药物的药理学
- 批准号:
10231036 - 财政年份:2013
- 资助金额:
$ 100.29万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 100.29万 - 项目类别:
Research Grant